CINV
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer (NCT05244577) | Shi Yanxia | 2022-01-18 |
| Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy (NCT01857232) | Acacia Pharma Ltd | 2013-10-01 |
Track CINV automatically
Every clearance here is in the API, with alerts when new ones post.